141.35
price up icon1.68%   2.34
after-market 시간 외 거래: 141.72 0.37 +0.26%
loading
전일 마감가:
$139.01
열려 있는:
$139.06
하루 거래량:
209.86K
Relative Volume:
0.62
시가총액:
$3.99B
수익:
$290.51M
순이익/손실:
$89.16M
주가수익비율:
47.27
EPS:
2.99
순현금흐름:
$119.18M
1주 성능:
-0.81%
1개월 성능:
+12.76%
6개월 성능:
-9.68%
1년 성능:
-20.42%
1일 변동 폭
Value
$139.06
$143.04
1주일 범위
Value
$135.86
$144.49
52주 변동 폭
Value
$122.80
$219.34

Krystal Biotech Inc Stock (KRYS) Company Profile

Name
명칭
Krystal Biotech Inc
Name
전화
(412) 586-5830
Name
주소
2100 WHARTON STREET, PITTSBURGH, PA
Name
직원
275
Name
트위터
@KrystalBiotech
Name
다음 수익 날짜
2024-11-04
Name
최신 SEC 제출 서류
Name
KRYS's Discussions on Twitter

KRYS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
KRYS
Krystal Biotech Inc
141.35 3.99B 290.51M 89.16M 119.18M 2.99
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-05 개시 Jefferies Buy
2024-08-06 다운그레이드 Citigroup Buy → Neutral
2023-11-20 개시 Goldman Buy
2023-10-24 개시 Cantor Fitzgerald Overweight
2023-10-12 개시 Citigroup Buy
2023-09-07 개시 Berenberg Buy
2023-04-18 개시 Stifel Buy
2023-02-28 업그레이드 Goldman Neutral → Buy
2022-08-25 다운그레이드 Goldman Buy → Neutral
2022-01-18 개시 BofA Securities Buy
2021-07-20 업그레이드 Goldman Neutral → Buy
2020-09-18 개시 B. Riley FBR Buy
2020-06-04 개시 Evercore ISI Outperform
2019-09-24 개시 Goldman Neutral
2019-08-06 재확인 H.C. Wainwright Buy
2019-06-24 재확인 Chardan Capital Markets Buy
2019-06-24 재확인 H.C. Wainwright Buy
2019-05-30 개시 Guggenheim Buy
2018-09-11 개시 Cantor Fitzgerald Overweight
모두보기

Krystal Biotech Inc 주식(KRYS)의 최신 뉴스

pulisher
Jun 17, 2025

Yousif Capital Management LLC Trims Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World

Jun 17, 2025
pulisher
Jun 16, 2025

Abeona Therapeutics' Zevaskyn Vs. Krystal Biotech's Vyjuvek (KRYS, ABEO) - Seeking Alpha

Jun 16, 2025
pulisher
Jun 14, 2025

Krystal Biotech (NASDAQ:KRYS) and VectivBio (NASDAQ:VECT) Critical Review - Defense World

Jun 14, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Estimates Krystal Biotech FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Krystal Biotech at Goldman Sachs Conference: Strategic Insights on VYJEVEC - Investing.com Canada

Jun 10, 2025
pulisher
Jun 05, 2025

Why Is Krystal Biotech (KRYS) Down 3.5% Since Last Earnings Report? - Yahoo Finance

Jun 05, 2025
pulisher
Jun 05, 2025

Exploring Three High Growth Tech Stocks In The US Market - simplywall.st

Jun 05, 2025
pulisher
Jun 03, 2025

H.C. Wainwright maintains Krystal Biotech stock Buy rating at ASCO 2025 - Investing.com Nigeria

Jun 03, 2025
pulisher
Jun 03, 2025

Krystal Biotech to Present at Goldman Sachs 46th Annual Global Healthcare Conference - The Manila Times

Jun 03, 2025
pulisher
Jun 03, 2025

How To Trade (KRYS) - news.stocktradersdaily.com

Jun 03, 2025
pulisher
Jun 02, 2025

Krystal Biotech Reports Promising Results for KB707 Trial - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

Implied Volatility Surging for Krystal Biotech Stock Options - Yahoo Finance

Jun 02, 2025
pulisher
Jun 02, 2025

Implied Volatility Surging For Krystal Biotech Stock Options - Barchart.com

Jun 02, 2025
pulisher
May 31, 2025

Head-To-Head Analysis: Genocea Biosciences (NASDAQ:GNCAQ) vs. Krystal Biotech (NASDAQ:KRYS) - Defense World

May 31, 2025
pulisher
May 28, 2025

Krystal Biotech Enters Oversold Territory (KRYS) - Nasdaq

May 28, 2025
pulisher
May 26, 2025

$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga

May 26, 2025
pulisher
May 26, 2025

Lazard Asset Management LLC Sells 922 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World

May 26, 2025
pulisher
May 24, 2025

D. E. Shaw & Co. Inc. Trims Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World

May 24, 2025
pulisher
May 23, 2025

Why We're Not Concerned Yet About Krystal Biotech, Inc.'s (NASDAQ:KRYS) 26% Share Price Plunge - simplywall.st

May 23, 2025
pulisher
May 23, 2025

Bank of America Corp DE Has $11.88 Million Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World

May 23, 2025
pulisher
May 21, 2025

Krystal Biotech stock hits 52-week low at $127.33 By Investing.com - Investing.com South Africa

May 21, 2025
pulisher
May 21, 2025

Krystal Biotech Holds Annual Stockholders Meeting - MSN

May 21, 2025
pulisher
May 21, 2025

Krystal Biotech stock hits 52-week low at $127.33 - Investing.com

May 21, 2025
pulisher
May 20, 2025

Krystal Biotech, Inc. (NASDAQ:KRYS) Position Cut by BNP Paribas Financial Markets - Defense World

May 20, 2025
pulisher
May 18, 2025

Citigroup Lowers Krystal Biotech (NASDAQ:KRYS) Price Target to $155.00 - Defense World

May 18, 2025
pulisher
May 16, 2025

Krystal Biotech (KRYS) Price Target Lowered by Citigroup | KRYS Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

The Analyst Verdict: Krystal Biotech In The Eyes Of 12 Experts - Benzinga

May 16, 2025
pulisher
May 16, 2025

Krystal Biotech (KRYS) Sees Price Target Cut Amid Sales Forecast Adjustment | KRYS Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

H.C. Wainwright maintains Buy on Krystal Biotech shares By Investing.com - Investing.com Nigeria

May 16, 2025
pulisher
May 14, 2025

Transcript : Krystal Biotech, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 11 - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore - MarketBeat

May 14, 2025
pulisher
May 13, 2025

Krystal Biotech's (NASDAQ:KRYS) Solid Earnings Have Been Accounted For Conservatively - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

Krystal Biotech Expands Gene Therapy Platform - TipRanks

May 13, 2025
pulisher
May 13, 2025

How the (KRYS) price action is used to our Advantage - news.stocktradersdaily.com

May 13, 2025
pulisher
May 12, 2025

FY2025 EPS Estimates for Krystal Biotech Lowered by Analyst - Defense World

May 12, 2025
pulisher
May 11, 2025

Cantor Fitzgerald Predicts Krystal Biotech FY2025 Earnings - Defense World

May 11, 2025
pulisher
May 11, 2025

Q4 EPS Estimates for Krystal Biotech Lifted by HC Wainwright - Defense World

May 11, 2025
pulisher
May 10, 2025

Biotech Alert: Searches spiking for these stocks today - Yahoo Finance

May 10, 2025
pulisher
May 09, 2025

If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today - Benzinga

May 09, 2025
pulisher
May 09, 2025

Krystal Biotech, Inc. (KRYS): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Insider Monkey

May 09, 2025
pulisher
May 09, 2025

10 Best Cancer Stocks to Invest in for Long-Term Gains - Insider Monkey

May 09, 2025
pulisher
May 07, 2025

H.C. Wainwright maintains Buy on Krystal Biotech shares - Investing.com Australia

May 07, 2025
pulisher
May 07, 2025

Krystal Biotech, Inc. (KRYS) Misses Q1 Earnings and Revenue Estimates - MSN

May 07, 2025
pulisher
May 07, 2025

Krystal Biotech "insulated" by domestic manufacturingPittsburgh Business Times - The Business Journals

May 07, 2025
pulisher
May 07, 2025

Krystal Biotech (KRYS) Price Target Lowered by Guggenheim | KRYS Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Krystal Biotech (KRYS) Faces Hurdles After Lowered Price Target - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Krystal Biotech (KRYS) Faces Hurdles After Lowered Price Target | KRYS Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Krystal Biotech, Inc. (NASDAQ:KRYS) Q1 2025 Earnings Call Transcript - Insider Monkey

May 07, 2025
pulisher
May 07, 2025

Krystal Biotech to Present at BofA Securities 2025 Health Care Conference - The Manila Times

May 07, 2025

Krystal Biotech Inc (KRYS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Krystal Biotech Inc 주식 (KRYS) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Krishnan Suma
President, R&D
Mar 13 '25
Sale
177.79
25,000
4,444,761
1,463,711
Krishnan Krish S
President and CEO
Mar 13 '25
Sale
177.79
25,000
4,444,763
1,533,056
Krishnan Krish S
President and CEO
Mar 13 '25
Sale
177.79
25,000
4,444,761
1,463,711
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
자본화:     |  볼륨(24시간):